QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ImmunityBio, Inc.
ImmunityBio, Inc.
University of California, San Francisco
Incyte Corporation
Bristol-Myers Squibb
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC